S.P.A Sofar, Net Worth

The estimated Net Worth of S.P.A Sofar, is at least $6.7 millió dollars as of 4 January 2017. S Sofar owns over 3,722,685 units of Asensus Surgical Inc stock worth over $6,702,675 and over the last 8 years S sold ASXC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

S Sofar ASXC stock SEC Form 4 insiders trading

S has made over 1 trades of the Asensus Surgical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently S bought 3,722,685 units of ASXC stock worth $5,211,759 on 4 January 2017.

The largest trade S's ever made was buying 3,722,685 units of Asensus Surgical Inc stock on 4 January 2017 worth over $5,211,759. On average, S trades about 3,722,685 units every 0 days since 2017. As of 4 January 2017 S still owns at least 19,266,098 units of Asensus Surgical Inc stock.

You can see the complete history of S Sofar stock trades at the bottom of the page.

What's S Sofar's mailing address?

S's mailing address filed with the SEC is VIA FIRENZE 40, , TREZZANO ROSA, L6, 20060.

Insiders trading at Asensus Surgical Inc

Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando és William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.

What does Asensus Surgical Inc do?

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.

Complete history of S Sofar stock trades at Asensus Surgical Inc

Asensus Surgical Inc executives and stock owners

Asensus Surgical Inc executives and other stock owners filed with the SEC include:

• Anthony Fernando,
  President, Chief Executive Officer, Director
• Anthony Fernando,
  Pres, CEO & Director
• Shameze Rampertab B.Sc. MBA, CA, CPA,
  Exec. VP & CFO
• Paul LaViolette,
  Independent Chairman of the Board
• Richard Pfenniger,
  Independent Director
• David Milne,
  Independent Director
• William Starling,
  Independent Director
• William Kelley,
  Independent Director
• Jane Hsiao,
  Independent Director
• Andrea Biffi,
  Independent Director
• Shameze Rampertab,
  Chief Financial Officer, Executive Vice President
• Dr. Stephanie M. Fitts,
  VP of Clinical, Quality and Regulatory Affairs
• Amanda Owens,
  Global Head of People
• Paul Ziegler Jr.,
  VP of Sales
• Joshua B. Weingard,
  Chief Legal Officer & Sec.
• Eric A Smith,
  Chief Commercial Officer
• Joseph P Slattery,
  EVP and CFO
• Aftab Kherani,
  Director
• Willam N Kelley,
  Director
• Todd Pope,
  President and CEO
• S.P.A Sofar,,
  10% owner
• Brett Farabaugh,
  Interim CFO
• Capital Iii Lp Aisling Capi...,
  
• Iv, Llcsv Life Sciences Fun...,
  
• Dennis Dougherty,
  Director
• Richard Mueller,
  Chief Operating Officer
• Kevin J Hobert,
  Director
• Elizabeth Kwo,
  Director